Goserelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist used to treat hormone-dependent conditions like breast cancer, prostate cancer, endometriosis, and uterine fibroids.
Mechanism of Action:
Goserelin initially stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), but prolonged use causes downregulation of GnRH receptors in the pituitary gland. This reduces the production of estrogen and testosterone, effectively leading to a temporary hormonal suppression.